Theralink Technologies, Inc.
THER · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $55 | $154 | $141 | $209 |
| - Cash | $997 | $25 | $25 | $208 |
| + Debt | $19,762 | $12,508 | $12,508 | $7,486 |
| Enterprise Value | $18,820 | $12,637 | $12,625 | $7,488 |
| Revenue | $179 | $202 | $202 | $170 |
| % Growth | -11.4% | 0% | 19.2% | – |
| Gross Profit | $139 | $152 | $152 | $144 |
| % Margin | 77.7% | 75.3% | 75.3% | 85% |
| EBITDA | -$2,484 | -$1,631 | -$1,631 | -$2,092 |
| % Margin | -1,385.7% | -805.6% | -805.6% | -1,232.2% |
| Net Income | $9,615 | $4,500 | $4,500 | -$19,879 |
| % Margin | 5,363.6% | 2,222.8% | 2,222.8% | -11,707.9% |
| EPS Diluted | 0.002 | 0 | 0 | -0.003 |
| % Growth | 700% | 0% | 106.3% | – |
| Operating Cash Flow | -$1,504 | -$753 | -$753 | -$1,742 |
| Capital Expenditures | -$155 | $0 | $0 | -$8 |
| Free Cash Flow | -$1,659 | -$753 | -$753 | -$1,750 |